Cargando…

Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease

Idiopathic Parkinson’s disease (PD) is characterized by a progredient degeneration of the brain, starting at deep subcortical areas such as the dorsal motor nucleus of the glossopharyngeal and vagal nerves (DM) (stage 1), followed by the coeruleus–subcoeruleus complex; (stage 2), the substantia nigr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gschmack, Eva, Monoranu, Camelia-Maria, Marouf, Hecham, Meyer, Sarah, Lessel, Lena, Idris, Raja, Berg, Daniela, Maetzler, Walter, Steigerwald, Frank, Volkmann, Jens, Gerlach, Manfred, Riederer, Peter, Koutsilieri, Eleni, Scheller, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188503/ https://www.ncbi.nlm.nih.gov/pubmed/35364741 http://dx.doi.org/10.1007/s00702-022-02495-4

Ejemplares similares

Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults
por: Huebschmann, Nathan A., et al.
Publicado: (2020)

Blood Level of Glial Fibrillary Acidic Protein (GFAP) Does not Correlate With Disease Progression in a Rat Model of Familial ALS (SOD1(G93A) Transgenic)
por: Jeffrey, Jeremy, et al.
Publicado: (2018)

Subacute Blindness Revealing an Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
por: Mabrouki, Fatima Zahra, et al.
Publicado: (2021)

Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
por: You, Huajing, et al.
Publicado: (2021)

Case report: Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as tuberculous meningitis
por: Qin, Ningxiang, et al.
Publicado: (2023)

Glial Fibrillary Acidic Protein in Blood as a Disease Biomarker of Neuromyelitis Optica Spectrum Disorders
por: Kim, Hyunjin, et al.
Publicado: (2022)

Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria
por: Lotz-Havla, Amelie S., et al.
Publicado: (2022)

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Associated With Area Postrema Syndrome: A Case Report
por: Gao, Xin, et al.
Publicado: (2021)

Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
por: Riederer, P., et al.
Publicado: (2021)

Autoimmune glial fibrillary acidic protein astrocytopathy coexistent with reversible splenial lesion syndrome: A case report and literature review
por: Lin, Jing, et al.
Publicado: (2023)

Comparison of glial fibrillary acidic protein-immunoglobulin G-associated myelitis with myelin oligodendrocyte glycoprotein-immunoglobulin G-associated myelitis
por: Sun, Mengyang, et al.
Publicado: (2023)

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
por: Abdelhak, Ahmed, et al.
Publicado: (2019)

Case Report: Need for Caution in the Diagnosis of GFAP Astrocytopathy—A Case of GFAP Astrocytopathy Coexistent With Primary Central Nervous System Lymphoma
por: Fang, Jia, et al.
Publicado: (2022)

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013)

Glial Fibrillary Acidic Protein (GFAP): Neuroinflammation Biomarker in Acute Ischemic Stroke
por: Amalia, Lisda
Publicado: (2021)

A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
por: Salari, Mehri, et al.
Publicado: (2023)

Cerebrospinal Fluid Biomarkers Are Associated With Glial Fibrillary Acidic Protein and αII-spectrin Breakdown Products in Brain Tissues Following Penetrating Ballistic-Like Brain Injury in Rats
por: DeDominicis, Kristen E., et al.
Publicado: (2018)

A Case Report of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Diagnosed After Long Term Diagnosis of Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids
por: Yin, He-Xiang, et al.
Publicado: (2020)

Radiographic evolution of myelitis in a case of glial fibrillary acidic protein (GFAP) astrocytopathy
por: Goyne, Christopher E, et al.
Publicado: (2023)

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
por: Fazeli, Badrieh, et al.
Publicado: (2023)

A Novel Mutation of GFAP Causing Adult-Onset Alexander Disease
por: Ciammola, Andrea, et al.
Publicado: (2019)

Elevated Levels of NLRP3 in Cerebrospinal Fluid of Patients With Autoimmune GFAP Astrocytopathy
por: Luo, Ying, et al.
Publicado: (2019)

GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask
por: Janigro, Damir, et al.
Publicado: (2022)

Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
por: Héraud, Charlotte, et al.
Publicado: (2021)

Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
por: Shir, Dror, et al.
Publicado: (2022)

Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes
por: Wulf, Maximilian, et al.
Publicado: (2022)

Regulatory mechanisms for 3′-end alternative splicing and polyadenylation of the Glial Fibrillary Acidic Protein, GFAP, transcript
por: Blechingberg, Jenny, et al.
Publicado: (2007)

Glial Purinergic Signaling in Neurodegeneration
por: Pietrowski, Marie J., et al.
Publicado: (2021)

Editorial: Glial Dysfunction in Epileptogenesis
por: Heuser, Kjell, et al.
Publicado: (2021)

L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
por: Riederer, Peter, et al.
Publicado: (2023)

Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses
por: Riederer, Peter, et al.
Publicado: (2020)

Supratentorial hydrocephalus with an anti‐glial fibrillary acidic protein (GFAP) antibody‐positive status: A case report
por: Tang, Lei, et al.
Publicado: (2022)

Reduced Programming Time and Strong Symptom Control Even in Chronic Course Through Imaging-Based DBS Programming
por: Lange, Florian, et al.
Publicado: (2021)

In vivo Imaging of Glial Activation in Alzheimer's Disease
por: Edison, Paul, et al.
Publicado: (2018)

The Glial Cells Respond to Spinal Cord Injury
por: Wang, Ruideng, et al.
Publicado: (2022)

Embryonic mouse medial neocortex as a model system for studying the radial glial scaffold in fetal human neocortex
por: Vaid, Samir, et al.
Publicado: (2022)

Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
por: Danysz, Wojciech, et al.
Publicado: (2021)

Ultrasensitive Determination of Glial-Fibrillary-Acidic-Protein (GFAP) in Human Serum-Matrix with a Label-Free Impedimetric Immunosensor
por: Ozcelikay, Goksu, et al.
Publicado: (2022)

Selegiline: a molecule with innovative potential
por: Tábi, Tamás, et al.
Publicado: (2019)

Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
por: García-Bermúdez, Mariana Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_97v8cheeucaekj4uch6qbbhu2h